CNS

Ultracaine D-S forte solution d/in 40 mg/ml+0.01 mg/ml 1.7 ml No. 100 (cartridge)

Ultracain® DS (Ultracain® DS) The drug is intended for use in the oral cavity and can be administered

Instructions for use BROMOCRIPTIN-RICHTER

Lamictal tablets 100 mg 30 pcs. in St. Petersburg

Lamictal, 30 pcs., 100 mg, tablets Orally. Epilepsy: adults and children over 12 years of age,

Betmiga, 50 mg, extended-release film-coated tablets, 30 pcs.

Description of the drug BETMIGA Mirabegron is a moderate time-dependent inhibitor of the CYP2D6 isoenzyme

Experience with the use of the atypical antipsychotic aripiprazole (Amdoal) in psychiatric practice: clinical observations

Aripiprazole is an antipsychotic, one of the brightest representatives of the “new wave” of atypical antipsychotics. Used in practice

Efficacy and safety of Alphagan R in the treatment of patients with primary open-angle glaucoma

Contraindications The drug Alphagan cannot be prescribed to patients with: Simultaneous therapy with drugs that inhibit monoamine oxidase; In children's

World experience in the use of topiramate (literature review)

Topamax, 60 pcs., 25 mg, capsules Effect of Topamax® on the concentrations of other antiepileptic drugs

Glucophage Long tablets with prolonged release 500 mg 30 pcs

Interaction Paracetamol reduces the effectiveness of uricosuric drugs. Simultaneous use of paracetamol in high doses increases the effect

Instructions for use DEPAKINE

Nosological classification (ICD-10) F95 Tics G25.3 Myoclonus G40 Epilepsy G40.0 Localized (focal) (partial) idiopathic

Zalasta Ku-tab, 28 pcs., 5 mg, oral dispersible tablets

Zalasta-Ku tab d/rassas 10 mg N28 (KRKA) There are very rare reports of the development of hyperglycemia and/or